WASHINGTON — President Biden’s pick to lead the Food and Drug Administration promised a key senator that he will crack down on drug companies abusing the so-called accelerated approval pathway within a month of his confirmation.
Robert Califf met with Sen. Ron Wyden (D-Ore.), the chair of the Senate Finance Committee, last week, STAT first reported. In a new letter made public Friday, Wyden provides a clear summation of his discussion with the nominee.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
